Loading candles…
Nath Bio-Genes Ltd, incorporated in 1993, operates in the agricultural biotechnology and seed production industries. The company specializes in the research, development, production, processing, and marketing of hybrid and genetically modified seeds. Its product range includes high-yield hybrid seeds for crops such as cotton, paddy, and vegetables. Nath Bio-Genes has a significant presence in the Indian seed market and also serves international markets. It does not have publicly listed shares or disclosed subsidiaries and is focused primarily on its core business of seed technology and supply.
This page is a live market overview for NATH BIO-GENES (I) LTD (NATHBIOGEN) on the NSE. As a listed security, NATH BIO-GENES (I) LTD is tracked in the Fast Moving Consumer Goods segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for NATHBIOGEN before placing trades on tick2trade.
As of the latest feed, NATHBIOGEN last traded at ₹157.68 on NSE, down ₹3.2 (1.99%) from the previous close of ₹160.88. Today's session range is ₹156 – ₹160.74, against a 52-week band of ₹126.15 – ₹204. Traded volume today stands at 56.67K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for NATHBIOGEN in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether NATHBIOGEN is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for NATH BIO-GENES (I) LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in NATHBIOGEN. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated NATHBIOGEN option chain page linked from this overview.
| Date |
|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 | 29 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 4 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 31 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 13 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 11 Jul 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 29 Apr 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.